F Dx Advisors, Inc. Repligen Corp Transaction History

F Dx Advisors, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	SELL	$170.78 - $208.42 $2,561 - $3,126	-15 Reduced 0.86%	1,734 $319,000
Q4 2023 Feb 12, 2024	BUY	$114.17 - $185.35 $199,683 - $324,177	1,749 New	1,749 $314,000
Q2 2023 Jul 17, 2023	BUY	$138.42 - $180.31 $304,247 - $396,321	2,198 New	2,198 $310,000
Q1 2020 May 13, 2020	BUY	$84.96 - $109.14 $17.7 Million - $22.7 Million	208,191 New	208,191 $1.01 Million

479

54.9M

297K

343K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.15B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of F Dx Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on F Dx Advisors, Inc. with notifications on news.